January 2017

TesoRx Announces Creation of LIPAC Oncology and Advancement of Oncology Pipeline
Read more

ASKA and TesoRx Announce Partnership to Develop Oral Testosterone
for the Japanese Market

Read more

June 2016

FDA grants orphan designation for TesoRx's unmodified Testosterone treatment for Constitutional Delay in Growth in Puberty (CDGP) for boys
Read more

February 2016

Landmark NIH-funded Testosterone Study finds modest benefits for men
Read more

April 2015

Official Opening of TesoRx Centre of Excellence at Western University
Read more

    October 2014
    TesoRx and Aspen Group Conclude Investment and Licensing Agreement
    Read more

      August 2014
      Tesorx crosses all of its ‘T’s’ with $10M series B-1
      Read more

        August 2014
        TesoRx Closes $10M in Funding, Secures Key Patent and Hires
        Renowned Urologist as Chief Medical Officer
        Read more

          June 2014
          TesoRx Featured in CEO/CFO Magazine
          Read more

            May 2014
            TesoRx Announces Participation at the American Urological Association
            (AUA) 2014 Conference.
            Read more

              August 2013
              TesoRx and CoreRx Announce Joint Venture to Manufacture First-in-Class Oral Testosterone Drug
              Read more

                December 2010
                TesoRx closes Series A funding round.
                Read more

                  July 2010
                  TesoRx licenses Testosterone Replacement Therapy technology
                  Read more

                  April 2010
                  Well-known pharma personality forms TesoRx
                  Read more